Related Party Transactions (Tables)

3 Months Ended

Jul. 31, 2026

The major components of Medtronic corporate and shared expenses for periods prior to the Separation were as follows:


	Three Months Ended
(in millions)		July 25, 2025
Cost of products sold		$	11
Research and development expense		8
Selling, general, and administrative expenses		66
Other operating expense (income), net		2
Total		$	87

The reconciliation of net transfers from parent between the condensed consolidated statements of equity and the condensed consolidated statements of cash flows were as follows:


	Three Months Ended
(in millions)		July 25, 2025
Net transfers from Parent per the Condensed Consolidated Statements of Equity		$	212


Stock-based compensation expense		(9)
Multi-employer pension expense		(2)
Other, net		1
Net transfers from Parent per the Condensed Consolidated Statements of Cash Flows		$	202